Live feed
Filing
SC 13G
SC 13G0001144204-15-008895·Carisma Therapeutics Inc.
Schedule 13G ownership disclosure
Eleven Biotherapeutics, Inc.
Security class unavailable · CUSIP: 286221106
Event date: 2014-02-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 19,566,261
- Percent of class
- 12.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-008895
- Form type
- SC 13G
- Filer
- Carisma Therapeutics Inc.
- CIK
- CIK 1485003
- Filed
- Feb 13, 2015
- Reporting period
- Feb 11, 2014
- Description
- Schedule 13G beneficial ownership